Mn Services Vermogensbeheer B.V. Neurocrine Biosciences Inc Transaction History

Mn Services Vermogensbeheer B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$106.07 - $132.76 $159,105 - $199,140	-1,500 Reduced 3.23%	45,000 $5.93 Million
Q4 2022 Feb 03, 2023	SELL	$106.72 - $127.06 $683,008 - $813,184	-6,400 Reduced 12.1%	46,500 $5.55 Million
Q3 2022 Nov 01, 2022	SELL	$92.03 - $107.81 $285,293 - $334,211	-3,100 Reduced 5.54%	52,900 $5.62 Million
Q2 2022 Aug 03, 2022	BUY	$75.79 - $100.07 $4.24 Million - $5.6 Million	56,000 New	56,000 $5.46 Million

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.